0001567619-23-004548.txt : 20230306 0001567619-23-004548.hdr.sgml : 20230306 20230306193028 ACCESSION NUMBER: 0001567619-23-004548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230302 FILED AS OF DATE: 20230306 DATE AS OF CHANGE: 20230306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PLATT PHILLIP JOHN CENTRAL INDEX KEY: 0001668926 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 23710607 MAIL ADDRESS: STREET 1: 5255 VIRGINIA AVE CITY: NORTH CHARLESTON STATE: SC ZIP: 29406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 4 1 doc1.xml FORM 4 X0306 4 2023-03-02 0 0001653477 Ingevity Corp NGVT 0001668926 PLATT PHILLIP JOHN C/O INGEVITY CORPORATION 4920 O'HEAR AVE, SUITE 400 NORTH CHARLESTON SC 29405 0 1 0 0 CAO & VP, Bus Transform Lead Common Stock 2023-03-02 4 M 0 2288 27.90 A 10811 D Common Stock 2023-03-02 4 S 0 2288 81.70 D 8523 D Common Stock 2023-03-02 4 M 0 1207 53.11 A 9730 D Common Stock 2023-03-02 4 S 0 1207 81.63 D 8523 D Common Stock 2023-03-02 4 M 0 2363 45.04 A 10886 D Common Stock 2023-03-02 4 S 0 2363 81.62 D 8523 D Common Stock 2023-03-02 4 S 0 2989 81.83 D 5534 D Employee Stock Option (right to buy) 27.90 2023-03-02 4 M 0 2288 0 D 2026-05-27 Common Stock 2288 0 D Employee Stock Option (right to buy) 53.11 2023-03-02 4 M 0 1207 0 D 2027-02-27 Common Stock 1207 0 D Employee Stock Option (right to buy) 45.04 2023-03-02 4 M 0 2363 0 D 2030-02-28 Common Stock 2363 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.64 to $81.73, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.65, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option, representing a right to purchase a total of 2,288 shares, became fully vested and exercisable on February 27, 2019. The option, representing a right to purchase a total of 1,207 shares, became fully vested and exercisable on February 27, 2020. The option, representing a right to purchase a total of 2,363 shares, became fully vested and exercisable on February 28, 2023. Phillip J. Platt By: Mavis Huger as Attorney-in-Fact 2023-03-06